Ben Haynor
Stock Analyst at Lake Street
(0.78)
# 3,392
Out of 4,670 analysts
37
Total ratings
32.14%
Success rate
-19.53%
Average return
Main Sectors:
Stocks Rated by Ben Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EKSO Ekso Bionics Holdings | Maintains: Buy | $2.5 → $2 | $0.69 | +189.44% | 2 | Oct 29, 2024 | |
| AWH Aspira Women's Health | Maintains: Buy | $7 → $5.5 | $0.75 | +633.43% | 2 | Aug 14, 2024 | |
| MYO Myomo | Maintains: Buy | $7 → $7.5 | $5.09 | +47.35% | 3 | Jul 9, 2024 | |
| ICCM IceCure Medical | Maintains: Buy | $1.9 → $2.9 | $0.71 | +307.19% | 3 | Mar 20, 2024 | |
| PROF Profound Medical | Maintains: Buy | $13 → $11 | $7.55 | +43.05% | 3 | Mar 11, 2024 | |
| EVGN Evogene | Initiates: Buy | $19 | $1.62 | +1,041.98% | 1 | Oct 2, 2023 | |
| NNOX Nano-X Imaging | Initiates: Buy | $15 | $6.36 | +127.99% | 1 | Sep 8, 2023 | |
| NMTC NeuroOne Medical Technologies | Maintains: Buy | $3.25 → $2.2 | $0.68 | +223.05% | 1 | Aug 15, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $5.45 → $4.1 | $0.84 | +385.32% | 3 | Aug 11, 2023 | |
| TTOO T2 Biosystems | Maintains: Neutral | $12 → $7 | $0.51 | +1,272.55% | 7 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5.55 | $2.79 | +98.92% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.15 → $4.75 | $2.65 | +79.25% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $8.89 | -21.26% | 3 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $4.14 | +449.52% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15,950 → $13,485 | $5.55 | +242,872.97% | 1 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,375 | $2.64 | +51,983.33% | 1 | Jun 26, 2020 |
Ekso Bionics Holdings
Oct 29, 2024
Maintains: Buy
Price Target: $2.5 → $2
Current: $0.69
Upside: +189.44%
Aspira Women's Health
Aug 14, 2024
Maintains: Buy
Price Target: $7 → $5.5
Current: $0.75
Upside: +633.43%
Myomo
Jul 9, 2024
Maintains: Buy
Price Target: $7 → $7.5
Current: $5.09
Upside: +47.35%
IceCure Medical
Mar 20, 2024
Maintains: Buy
Price Target: $1.9 → $2.9
Current: $0.71
Upside: +307.19%
Profound Medical
Mar 11, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $7.55
Upside: +43.05%
Evogene
Oct 2, 2023
Initiates: Buy
Price Target: $19
Current: $1.62
Upside: +1,041.98%
Nano-X Imaging
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $6.36
Upside: +127.99%
NeuroOne Medical Technologies
Aug 15, 2023
Maintains: Buy
Price Target: $3.25 → $2.2
Current: $0.68
Upside: +223.05%
DarioHealth
Aug 11, 2023
Maintains: Buy
Price Target: $5.45 → $4.1
Current: $0.84
Upside: +385.32%
T2 Biosystems
Jul 13, 2023
Maintains: Neutral
Price Target: $12 → $7
Current: $0.51
Upside: +1,272.55%
May 19, 2023
Maintains: Buy
Price Target: $10 → $5.55
Current: $2.79
Upside: +98.92%
May 17, 2023
Maintains: Buy
Price Target: $5.15 → $4.75
Current: $2.65
Upside: +79.25%
May 4, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $8.89
Upside: -21.26%
Feb 17, 2023
Initiates: Buy
Price Target: $23
Current: $4.14
Upside: +449.52%
May 26, 2022
Maintains: Buy
Price Target: $15,950 → $13,485
Current: $5.55
Upside: +242,872.97%
Jun 26, 2020
Initiates: Buy
Price Target: $1,375
Current: $2.64
Upside: +51,983.33%